Litcius/Paper detail

Letter to the Editor: A multi-society Delphi consensus statement on new fatty liver disease nomenclature

Jay H. Hoofnagle, Edward Doo

2023Hepatology25 citationsDOI

Abstract

Liver Disease Research Branch, Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD Short Title: New Names for NASH The content and opinions expressed in this letter are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. Abbreviations: MASH, metabolic dysfunction-associated steatohepatitis; MASLD, metabolic dysfunction associated steatotic liver disease; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases; NIH, National Institutes of Health. Correspondence Jay Hoofnagle, Room 6005, Democracy II, 6707 Democracy Blvd, Bethesda, MD 20817. Email: [email protected]

Topics & Concepts

SteatohepatitisMedicineFatty liverConsensus conferenceNonalcoholic fatty liver diseaseGastroenterologyInternal medicineDiseaseDiabetes mellitusNonalcoholic steatohepatitisFamily medicineEndocrinologyLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseasePancreatitis Pathology and Treatment